Halperin brings over 35 years of pharmaceutical industry experience to the newly created role. Prior to joining Conexus, he held several senior practice leadership roles at Accenture, Tata Consulting Services, etc., as well as in the Technology function at companies such as Johnson & Johnson, Merck, and Otsuka Pharmaceuticals. Most recently, he established and led the internal IT function for a bio-pharmaceutical start-up where he was responsible for implementing a new technology infrastructure and application portfolio to support the Commercial, R&D, and Corporate Support functions within the company.
In Conversation: Sunitha Venkatanarayanan, Practice Lead, Data Science and Insights at Conexus Solutions
We recently spoke with Sunitha Venkatanarayanan, Conexus’ Practice Lead (Data Science & Insights), about her own career journey, the power of data science, and what the company has to offer small to midsize pharma and life sciences companies.
As a Director of Client Services, Jim Rondinone’s role is to lead a team of Program Managers who oversee our service delivery to the Company’s customers. He will help ensure that Conexus’ Program Managers continue to grow and develop their skills to become more effective in their role, thereby increasing the value of the company’s deliverables and ultimately strengthening the relationships that the team has with their customers.
Conexus Solutions, Inc. Ranks No. 1657 on Inc. 5000, Inc. Magazine’s Annual List of America’s Fastest Growing Private Companies
Inc. Magazine announced that Conexus Solutions, Inc. has ranked No. 1657 on its annual Inc. 5000 list, a prestigious list of the nation’s most successful private companies. The list is not only a remarkable achievement but a distinguished editorial award and a celebration of innovation. Many of the world’s most well-known companies such as Microsoft, Patagonia, Zappos, and more gained their national exposure as list honorees.
Conexus Solutions, Inc. and WhizAI Announce Strategic Partnership to Create an Analytics Powerhouse for Emerging Pharma
Conexus Solutions, Inc. has announced a strategic partnership with WhizAI, the only AI-powered analytics platform purpose-built for life sciences and healthcare. The partnership brings together Conexus’ team of life science industry veterans and technology experts who have a passion for solving operational challenges and WhizAI’s ability to transform analytics with an artificial intelligence platform optimized for the life sciences.
Conexus Solutions, Inc. announces the formation of their strategic Advisory Board. Conexus has shown tremendous growth over the last five years, and they believe the formation of their advisory board will help them continue on their upward trajectory within the industry. The Conexus advisory board features two highly esteemed industry professionals with decades of experience, Chris French and Chuck Saldarini.
Small and mid-sized life sciences companies’ sales teams require the ability to engage with healthcare professionals (HCPs) anytime, anywhere, and get messages to more customers without compromising their team’s productivity. With Veeva’s approved email solution, reps can send HCPs tailored content to augment the face-to-face visit, reach more low-access and no-see HCPs, and provide faster, more responsive service.
Like many other industry sectors, the bioscience space has been slow to embrace the digital future. Investing in and building out an integrated, enterprise-wide digital platform always played second fiddle to funding R&D, hiring, manufacturing and the commercial function. A Deloitte “Perspectives” piece perhaps framed the current state of digital transformation in the life sciences best, suggesting that organizations need to move “…from merely doing digital to being digital” or risk irrelevancy.
Conexus Solutions, Inc. announced that it has achieved ISO 27001:2013 Certification from SGS NA on April 21, 2022.
Conexus was launched in 2016, with the goal of providing outsourced commercial operations for pharmaceutical and life sciences companies. Conexus primarily focuses on the small and mid-size market, which has been somewhat ignored by other service providers, Chief Executive Officer and Founder, Akshay Kapadia told BioBuzz.